Loading...
 
Toggle Health Problems and D

COVID-19 was 19X more likely if low vitamin D (may be invalid data)– April 2020

Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (Covid- 2019)

Mark M. Alipio April 9, 2020
Department of Radiologic Technology, College of Allied Health Sciences, Davao Doctors College
Gen. Malvar St., Davao City 8000, Davao del Sur, Philippines, Office +63 (082) 222 0850, markalipiorrt at gmail.com

Chart of data by GrassrootsHealth
Image

Chart of data in German VitaminDService
German vertical axis is the number of people in each group, GRH vertical axis is a % of 100%
Image
To the Editor:
The rapid spread of Covid-2019 in many areas of the world calls for preventive health measures. Although basic guidelines on infection control are recommended, treatment has remained the best choice to avert mortality. However, for the time being, there are no known vaccines for the disease. This has driven several researchers in the world to assess the effectiveness of previously used treatments for severe acute respiratory syndrome (SARS) such as lopinavir.1 Clinical trials for these vaccines could take more time, hence, palliative drugs have been developed to alleviate the severity of the disease.
Vitamin D has been proven to reduce risk of getting common cold.2 It also enhances cellular immunity,3 modulates adaptive immunity,4 and enhances expression of antioxidation-related genes.5 Hence, several authors proposed Vitamin D supplementation to prevent and treat Covid- 2019.6,7,8 To the best of my knowledge, no clinical trials have been conducted yet to determine the potency of Vitamin D in suppressing SARS-CoV-2 strain. A statistical analysis of the association between Vitamin D levels and clinical outcomes of Covid-2019 patients has not been described. In this paper, I used multinomial logistic regression to predict clinical outcomes of patients infected with Covid-2019 based on 25-hydroxyvitamin D [25(OH)D] levels, the barometer for Vitamin D status.
Using the database of three hospitals in Southern Asian countries, I conducted a retrospective multicentre study of 212 cases with laboratory-confirmed infection of SARS-CoV-2. Data pertaining to clinical features and serum 25(OH)D levels were extracted from the medical records. No other patient information was provided to ensure confidentiality. I classified the cases as follows: (1) mild - mild clinical features without pneumonia diagnosis, (2) ordinary - confirmed pneumonia in chest computer tomography with fever and other respiratory symptoms, (3) severe
-hypoxia (at most 93% oxygen saturation) and respiratory distress or abnormal blood gas analysis results (PaC〇2 >50 mm Hg or Pa〇2 < 0 mm Hg), and (4) critical - respiratory failure requiring intensive case monitoring. Classification was based on a previous work.9 I also classified the vitamin D status of the cases based on their serum 25(OH)D level: (1) normal - 25(OH)D of > 30 ng/ml, (2) insufficient - 25(OH)D of 21-29 ng/ml, and (3) deficient - 25(OH)D of < 20 ng/ml.
A previous report guided this classification.10 For statistical analysis, I used Mann-Whitney U and x2 tests to compare differences in the clinical outcomes. Multinomial logistic regression was used to explore the association between serum 25(OH)D level and clinical outcomes of the cases. Frequency and percentage were used for categorical variables. Mean was used for continuous variables. A p-value below 0.01 was considered statistically significant. Ethics approval was considered exempt owing to the nature of the study and open-access data used. All names were originally hidden by the health governing bodies to ensure patient confidentiality.
Table 1. Descriptive statistics
Image
Note: OR = odds ratio associated with the effect of a one standard deviation increase in the predictor.
Table 2. Multinomial logistic regression analysis
Image
Of the 212 (100.0%) cases of Covid-2019, 49 (23.1%) were identified mild, 59 (27.8%) were ordinary, 56 (26.4%) were severe, and 48 (22.6%) were critical (Table 1). Mean serum (OH)D level was 23.8 ng/ml. Serum (OH)D level of cases with mild outcome was 31.2 ng/ml, 27.4 ng/ml for ordinary, 21.2 ng/ml for severe, and 17.1 ng/ml for critical. Serum (OH)D levels were statistically significant among clinical outcomes (p<0.001). A total of 55 (25.9%) cases had normal Vitamin D status, majority of which (85.5%) were identified mild. A total of 80 (37.7%) cases had insufficient Vitamin D status, majority of which (43.8%) were ordinary. Cases identified as Vitamin D-deficient were 77 (36.3%), majority of which were severe (40.3%).
Vitamin D status is significantly associated with clinical outcomes (p<0.001).
A multinomial logistic regression analysis reported that the odds of having a mild clinical outcome rather than an ordinary outcome were approximately 1.63 times (OR=0.614, p=0.007) for each standard deviation increase in serum (OH)D (Table 2).
Also, for each standard deviation increase in serum (OH)D, the odds of having a mild clinical outcome rather than a severe outcome were approximately 7.94 times (OR=0.126, p<0.001) while interestingly, the odds of having a mild clinical outcome rather than a critical outcome were approximately more than 19.61 times (OR=0.051, p<0.001).

More generally, the odds of having a mild clinical outcome increase when serum (OH)D level increases. Alternatively, the odds of having a critical outcome increase when serum (OH)D level decreases. This means that serum (OH)D level in the body could account for the clinical outcomes of the patients infected with Covid-2019. An increase in serum (OH)D level in the body could either improve clinical outcomes or mitigate worst (severe to critical) outcomes. On the other hand, a decrease in serum (OH)D level in the body could worsen clinical outcomes of Covid-2019 patients. In this case, Vitamin D supplementation may play an important role to raise 1,25- dihydroxyvitamin D [1,25(OH)2D], the biologically active form of Vitamin D in the blood.

In conclusion this study provides substantial information to clinicians and health policy-makers. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Covid-2019 based on increasing odds ratio of having a mild outcome when serum (OH)D level increases. Further research may conduct randomized controlled trials and large population studies to evaluate this recommendation.

References

  1. Sohrabi, C., Alsafi, Z., ONeiU, N., Khan, M., Kerwan, A., Al-Jabir, A., ... & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVJD-19). International Journal of Surger
  2. Lei, G. S., Zhang, C., Cheng, B. H., & Lee, C. H. (2017). Mechanisms of action of vitamin D as supplemental therapy for Pneumocystis pneumonia. Antimicrobial agents and chemotherapy, 61(10), e01226-17. y.
  3. Rondanelli, M., Miccono, A., Lamburghini, S., Avanzato, I., Riva, A., Allegrini, P., ... & Perna, S. (2018). Self-care for common colds: the pivotal role of vitamin D, vitamin C, zinc, and Echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds 一Practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. Evidence-Based Complementary and Alternative Medicine, 2018.
  4. Cantorna, M. T. (2010). Mechanisms underlying the effect of vitamin D on the immune system. Proceedings of the Nutrition Society, 69(3), 286-289.
  5. Sharifi, A., Vahedi, H., Nedjat, S., Rafiei, H., & Hosseinzadeh-Attar, M. J. (2019). Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. Apmis, 127(10), 681-687.
  6. Wimalawansa, S. J. (2020). Global epidemic of coronavirus--COVID-19: What we can do to minimize risks. European XXXXX, 7(3), 432-438.
  7. Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.姓/rien/s, 12(4), 988.
  8. Braiman, M. (2020). Latitude Dependence of the COVID-19 Mortality Rate—A Possible Relationship to Vitamin D Deficiency?. Axx mlable at SSRN3561958.
  9. Wang, Y., Liu, Y., Liu, L., Wang, X., Luo, N., & Ling, L. (2020). Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China. The Journal of infectious diseases.
  10. Holick, M. F. (2009). Vitamin D status: measurement, interpretation, and clinical application. Annals of epidemiology, 19(2), 73-78.

COVID-19 treated by Vitamin D - studies, reports, videos


Facebook has a COVID-19 and Vitamin D page - invitation only
1200 members as of July 5, 2020
Image

Intervention Clinical Trials
Intervention Trial Summary Checked July 8
Image

Observational Clinical Trials

Vitamin D Dosing Recommendations for COVID-19

  • Portion of image from June 5 video (below)
    • Image
  • Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic Metabolism, June 2, FREE PDF, peer-reviewed publication
    • "Preventive doses of vitamin D3 of 10,000 IU/day for 4 weeks followed by 5000 IU/day to reach a target 25(OH)D level of 100–150 nmol/L [24], and treatment doses >6000 IU/day in deficient individuals to reach a similar level and reduce disease progression [48], are suggested. ""
    • Comment: Strange that the treatment dose is less than the prevention dose. Note treatment dose will take > 3 months to help
      • Perhaps they meant the treatment dose to be 60,000 IU, not 6,000 IU
  • Perspective: improving vitamin D status in the management of COVID-19 May 22 free PDF
    • If low: 50,000 IU twice a week at the diagnosis (100,000 IU total)., then 50,000 IU taken once a week for the 2nd and 3rd weeks.
      • Note: VitaminDWiki believes that this dosing is not large enough for prevention, much less treatment
  • COVID-19 might be prevented in 2 months by 50,000 IU weekly – May 12, 2020
  • for people who have not been taking any vitamin D BusinessWorld May 22 - by Dr Renu Mahtani in videos below
    • Vitamin D 60k IU twice a week for two weeks to be followed by 60k once a week for the next six weeks.
    • or Vitamin D 60k IU daily for three days to be followed by 60k weekly for the total period of two months.
    • Thus 480,000 IU total, No Vitamin D testing needed

Some people wanted improved immune systems, so took more vitamin D

COVID-19 associated with Low Vitamin D

Vitamin D levels are lower in those who test positive for COVID-19 -[doi:10.3390/nu12051359| Nutrients] May 09

    • Image
  • [https://articles.mercola.com/sites/articles/archive/2020/05/08/vitamin-d-level-correlated-to-covid19-outcomes.aspx?cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20200508Z1&et_cid=DM527863&et_rid=867359477 |Vitamin D Level Is Directly Correlated to COVID-19 Outcome] Mercola May 8
    • Overview of many studies and video by Ivor Cummins
  • [https://www.sciencedaily.com/releases/2020/05/200507131012.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fvitamin_d+%28Vitamin+D+News+--+ScienceDaily%29 |Vitamin D linked to low virus death rate in 20 countries in Europe] Science Daily May 7
  • [https://doi.org/10.1101/2020.05.01.20087965 |Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes] May 6 preprint
    • Excellent extensive use of Causal Influence AI to discover associations.
    • I have suspected that Causal Influence could be much better, far lower cost, and faster than the use of RCTs
  • [https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3586555|Evidence of Protective Role of Ultraviolet-B (UVB) Radiation in Reducing COVID-19 deaths] preprint May 7
    • "permanent unit increase in UVI is associated with a 2.2 % decline in daily growth rates of cumulative COVID-19 deaths [p < 0.01]
    • as well as a 1.9 % decline in the daily growth rates of CFR [p < 0.05]
    • 64 countries, 78 days, 6 UVI models
  • [https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3593258#.XrE0oF1wSjU.twitter |Vitamin D Level of Mild and Severe Elderly Cases of COVID-19: A Preliminary Report] May 5
    • 176 seniors in S. Asia - published in India
    • Image
  • Almost everyone with COVID-19 in a Louisiana ICU had low vitamin D – April 29, 2020
  • COVID-19 mortality rate highest North of 35 degrees latitude (Vitamin D) – April 20, 2020
  • COVID-19 was 19X more likely if low vitamin D (may be invalid data)– April 2020 Philippines
    • The raw data has strange gaps in the vitamin D levels
    • Image
  • Research Suggests a Link Between Vitamin D Deficiency and COVID-19 Deaths May 5
  • Indonesia preprint 13X if vitamin D insufficient,19X for patients who are vitamin D deficient.
    • VitaminDWiki has requested but has not yet access to the raw data
  • COVID-19 infections associated with very low vitamin D – Turin Italy – March 2020

Speculation

Image

Higher levels of vitamin D result in fewer COVID-19 problems

VIDEOS and PODCASTS


Search Google Scholar for "COVID-19" "Vitamin D"
17,200 publications as of July 1, 2020


Groups which ignore Vitamin D possibility

  • The Wellcome-Gates COVID-19 Accelerator initiative expressly prohibits funding for Vitamins.


Short URL for this section = is.gd/COVIDMedia




Attached files

ID Name Comment Uploaded Size Downloads
13772 German 19X.jpg admin 29 Apr, 2020 14:14 54.42 Kb 2132
13759 Alipio chart.jpg admin 22 Apr, 2020 17:29 88.17 Kb 4845
13745 table 2.jpg admin 18 Apr, 2020 22:50 15.40 Kb 3122
13744 COVID-19 and Vitamin D deficiency.jpg admin 18 Apr, 2020 21:31 58.06 Kb 3288
See any problem with this page? Report it (FINALLY WORKS)